Home › Therapeutic areas › Immunology › Ulcerative Colitis
Ulcerative Colitis (3 companies)
Companies with an active program in Ulcerative Colitis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| EVMN | Evommune, Inc. | DermatologyImmunologyNeurology | 1 | Phase 2 | 6 |
| SYRE | Spyre Therapeutics, Inc. | Immunology | 6 | Phase 2 | 12 |
| VNDA | Vanda Pharmaceuticals Inc. | CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare | 1 | Approved | 26 |
No companies match.